person

Paul-Henri W.

Country
France
Department
Intensive Care

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 21 partner sites.

Specializations

Cardiovascular Critical Care

Investigator Wicky concentrates on acute cardiac interventions and peri‑operative management in intensive care settings.

  • Transcatheter Aortic Valve Implantation
  • Coronary Artery Bypass Grafting
  • Aortic Bioprosthesis Management
  • Frequent Premature Ventricular Complexes
  • Post‑operative Atrial Fibrillation Prevention

Research integrates surgical techniques with critical‑care monitoring to improve cardiovascular outcomes.

Gastrointestinal and Hepatobiliary Oncology

His work addresses malignant diseases of the liver, biliary tree, stomach and pancreas.

  • Advanced Biliary Tract Cancer
  • FGFR2b‑Positive Gastric Adenocarcinoma
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Locally Advanced Hepatocellular Carcinoma
  • Colorectal Cancer with Microsatellite Instability

Focus includes surgical resections, targeted molecular profiles and adjuvant strategies.

Genitourinary and Prostate Cancer Research

He evaluates therapeutic approaches for malignancies of the prostate, bladder and kidney.

  • Metastatic Castration‑Resistant Prostate Cancer
  • High‑Risk Muscle‑Invasive Bladder Cancer
  • Renal Cell Carcinoma
  • Prostate Cancer with PTEN Deficiency
  • Neoadjuvant Hormone Therapy in Localized Prostate Cancer

Efforts combine hormonal manipulation, immunomodulation and precision oncology.

Immune‑Based and Molecular Targeted Therapies

He investigates checkpoint inhibition, FGFR inhibition and novel immunotherapeutic combinations.

  • PD‑L1 Checkpoint Blockade
  • FGFR Inhibitors (e.g., Pemigatinib)
  • Dual Durvalumab‑Tremelimumab Regimens
  • CAR‑T Cell‑Related Antigen Targeting
  • Vaccine‑Induced CD4‑Th1 Responses

Studies aim to match molecular alterations with tailored therapeutic agents.

Infectious and Metabolic Disorders

His portfolio also covers severe infections and metabolic disease management in critical settings.

  • Sepsis Antibiotic Strategies
  • Mycobacterium avium Complex Pulmonary Therapy
  • Type 2 Diabetes Remission after Bariatric Surgery
  • Atrial Fibrillation Stroke Prevention
  • Antiplatelet Duration after TAVI

Research integrates antimicrobial stewardship with metabolic outcome optimization.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.